In this study, a pancancer analysis of the expression and immunological characteristics of IFITM3 was first performed, and the results revealed that IFITM3 was highly correlated with immunological factors in most cancers, but the tightest correlation was found in bladder cancer (BLCA). The gene discussed is IFITM3; the disease is urinary bladder cancer.